Terms of Use
These terms define the product, program, and advice boundaries.
Last updated September 29, 2026
Read the professional readiness actions.
Operator
This website is operated by NW Micelle Therapeutics, Inc., trading as Micelle Therapeutics, part of the NW PharmaTech group. Correspondence address: NW Micelle Therapeutics, Inc., c/o NW PharmaTech Ltd, Beaufort Gardens, Knightsbridge, London SW3 1PW, United Kingdom. Contact: team@nwpharmatech.com.
Purpose
The website provides information about Micelle 60, sample records, and how a care organization can request a briefing. It does not provide medical advice, and no product is offered for retail purchase through it.
Programs
Where the website describes programs run by the Centers for Medicare & Medicaid Services, it does so for orientation. Each organization is responsible for its own participation, documentation, and submissions. The Micelle 60 Access Program is Micelle’s implementation support set; it is not a CMS program and is not sponsored or approved by CMS.
Examples
Example pages use sample data and visible example labels. Coming dates describe planned availability, not a service already in operation. Examples show how services are intended to work; they are not services in operation.
Accuracy
We work to keep information accurate and current; it may change without notice.
Content
The content is ours or used with permission. You may print or download pages for your organization’s internal evaluation.
Links
Links to other websites are provided for convenience; we are not responsible for their content.
Contact
team@nwpharmatech.com